Primary Article

A Clinical Review of Small Bowel Neoplasms

Authors: GEORGE WATERHOUSE MD, J. L. SKUDLARICK MD, R. BENTON ADKINS MD

Abstract

Small bowel neoplasms represent 3% to 6% of all gastrointestinal tumors and less than 1% of all malignancies. Of 92 cases of small bowel tumor seen between 1950 and 1978, 26% were benign and 74%, malignant. The symptoms and sighs are related to the specific disease. Of the malignant neoplasms, 38% were carcinoid; 33%, adenocarcinoma; 14%, leiomyosarcoma; 11%, lymphosarcoma; and 4%, others. The average time of survivial for the malignant group was 16 months. The advanced stage of disease at the time of diagnosis is thought to be the reason for the generally poor prognosis. Attention to vague symptoms and an aggressive diagnostic evaluation are important if survival is to be improved.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References